Abeba Teklehaimanot to Treatment Outcome
This is a "connection" page, showing publications Abeba Teklehaimanot has written about Treatment Outcome.
Connection Strength
0.082
-
Longitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Pharmacotherapy in Major Depressive Disorder in Older Adults: Phase 2 of the PRIDE Study. Am J Geriatr Psychiatry. 2022 01; 30(1):15-28.
Score: 0.021
-
Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Venlafaxine in Geriatric Depression: Phase 1 of the PRIDE Study. Am J Geriatr Psychiatry. 2020 03; 28(3):304-316.
Score: 0.018
-
Right Unilateral Ultrabrief Pulse ECT in Geriatric Depression: Phase 1 of the PRIDE Study. Am J Psychiatry. 2016 Nov 01; 173(11):1101-1109.
Score: 0.015
-
A Novel Strategy for Continuation ECT in Geriatric Depression: Phase 2 of the PRIDE Study. Am J Psychiatry. 2016 Nov 01; 173(11):1110-1118.
Score: 0.015
-
Weibull mixture regression for marginal inference in zero-heavy continuous outcomes. Stat Methods Med Res. 2017 Jun; 26(3):1476-1499.
Score: 0.013